The IVIG treatment response in autoimmune polyendocrine syndromes type 2 with anti-GAD65 antibody-associated stiff person syndrome: a case report and literature review.
Yang Y, Jiang H, Yang W, Wang H, Wang M, Li X, Huang P, Fang S, Hao W, Yang Y, Zhao F, He W.
Front Immunol. 2025 Jan 7;15:1471115. doi: 10.3389/fimmu.2024.1471115. eCollection 2024.
PMID:39840065
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.
N Engl J Med. 2008 Mar 6;358(10):1018-28. doi: 10.1056/NEJMoa0706487.
PMID:18322283
Delayed diagnosis of the full triad autoimmune polyendocrine syndrome type 2 with adrenal crisis: a case report and literature review.
Yao Z, Chen H, Hu X, Ge D, Xu X, Xu D.
Front Immunol. 2025 May 9;16:1563629. doi: 10.3389/fimmu.2025.1563629. eCollection 2025.
PMID:40416965
Introduction: Autoimmune polyendocrine syndrome type 1 (APS-1): a rare monogenic disorder as a model to improve understanding of tolerance and autoimmunity.